The Health Professions Council of South Africa HPCSA is warning that unregistered practitioners are putting lives at risk. New cases of “bogus doctors” continue to surface. “If you’re in the hands of an unqualified person, you’re as well as dead,” says. The council is responsible for registering medical doctors and other health professionals. It also investigates complaints about practitioners practising…
Category: February 2026
-
Sizwe Hosmed Curatorship Exposes R522m in Duplicate Claims
South Africa’s medical scheme regulator has escalated its fight to keep Sizwe Hosmed under curatorship. An affidavit filed in the High Court in Pretoria alleges serious governance and payment failures at the troubled scheme. The allegations include potential duplicate claims exceeding R522m, stale claims worth R81m, procurement concerns, and alleged misuse of a corporate credit card. The affidavit was filed…
-
Medical Aid Tax Credit Cut Could Reshape SA’s Private Healthcare
South Africa’s healthcare funding model may be nearing a defining break point. The proposed withdrawal of medical aid tax credits, starting with high-income earners in 2026 and extending to all taxpayers by 2027, is framed as a revenue-raising measure to support the National Health Insurance (NHI). But it is also a structural shift in how healthcare is financed. The change…
-
Gauteng Health Turmoil as MEC Backs Tainted Department Head
Renewed scrutiny dogs Gauteng health’s leadership after Health MEC Nomantu Nkomo-Ralehoko publicly defended her former head of department (HOD), Lesiba Malotana, despite a Special Investigating Unit (SIU) lifestyle audit flagging him as “high risk.”This situation highlights the Gauteng Health Turmoil as the province faces pressure over both governance and patient care. Additionally, it adds fuel to an already heated political…
-
Sizwe Hosmed Curatorship Under Fresh Scrutiny
The curator of Sizwe Hosmed responded to critics after they launched legal efforts to liquidate her business and sequester her estate. Lebogang Mpakati, a registered business rescue practitioner, said the proceedings are private matters. She said they have no bearing on her ability to stabilise the troubled medical scheme. Mpakati is facing pressure from the scheme’s suspended board of trustees. The…
-
Eli Lilly 2026 Guidance Signals Momentum In Obesity Care
Eli Lilly has forecast 2026 profit and revenue above Wall Street expectations, reinforcing how fast the obesity market is reshaping Big Pharma growth plans. The recent Eli Lilly 2026 Guidance reflects the company’s confidence in strong future performance. The company also beat estimates for fourth-quarter earnings, helped by strong demand for its injectable weight-loss and diabetes medicines. For Q4, Lilly…
-
Perinatal Mental Health: Risks and Solutions in Pregnancy
As National Pregnancy Week runs from 3-7 February, the South African Society of Psychiatrists (Sasop) is calling on healthcare providers and expectant mothers to treat perinatal mental health symptoms in pregnancy as urgent medical issues. The society says between 16% and 50% of women in South Africa experience depression or anxiety during pregnancy. It adds that up to one in…
-
Healthcare Investment Drives Growth and Productivity
Leaders in emerging markets are under pressure. Economies are strained. Geopolitical tension is rising. Growth must be sustained. Yet policy debates often miss one core driver of national performance: health. In fact, healthcare investment drives growth by improving productivity and stability for these economies. A nation’s health is tightly linked to its economic strength. Health care is not a side…
-
US WHO Withdrawal Official, Organisation Plans Deep Cuts
The US WHO Withdrawal became effective in late January 2026, ending Washington’s formal membership in the World Health Organisation after a one-year notice period triggered by an executive order signed on Inauguration Day of Donald Trump’s second term. The administration argues the US pays more than peer nations and has criticised the WHO’s Covid-19 response and governance. The WHO disputes…
-
Human HIV Vaccine Trial Begins With BRILLIANT 011
South Africa has launched its first-ever human HIV vaccine trial. It is a landmark for a country that remains the global epicentre of HIV. The long-term ambition is clear. Scientists want a safe, affordable vaccine given in the first year of life, with no need for repeat doses. The trial, known as BRILLIANT 011, is a first-in-human study. It has…